BMA vs INDB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BMA

37.9
AI Score
VS
BMA Wins

INDB

36.0
AI Score

Investment Advisor Scores

BMA

38score
Recommendation
AVOID NEW MONEY

INDB

36score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BMA INDB Winner
Forward P/E 3.0979 9.6246 BMA
PEG Ratio 0.4681 10.9971 BMA
Revenue Growth 1.2% 24.5% INDB
Earnings Growth 3.5% 176.9% INDB
Tradestie Score 37.9/100 36.0/100 BMA
Profit Margin 9.0% 32.7% INDB
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

BMA 1M: -11.0% · 3M: -27.5% INDB 1M: +9.9% · 3M: -0.6%

Current Technical Phase

BMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.7%), weak momentum, RSI 33

RSI (14): 33.0 · Price: $57.83

INDB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.2 · Price: $84.81

Fundamentals Snapshot

Metric BMA INDB
Market Cap — —
Forward P/E 0.0 10.2
Trailing P/E 12.0 12.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 1.0% 1.0%
Operating Margin 0.3% 0.5%
EPS 4.89 6.79
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, BMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.